Questioning the value of screening for gonorrhoea in symptomless heterosexual men.
These two papers discuss whether gonorrhoea screening of asymptomatic heterosexual men with no contact history should continue in UK genitourinary medicine clinics. Currently, most clinics routinely test all attenders. This requires an estimated 330,000 tests annually to detect 915 positives (1 in 361). The benefits to these patients are uncertain but the costs are huge and could fund currently unprovided services such as oral contraceptive provision or HIV testing before terminations of pregnancy. However stopping testing would deny individuals the reassurance they seek, prevent early detection of outbreaks and fail to detect carriers who go on to cause morbidity in their partners. On this view, the availability of non-invasive tests should be used to widen screening.
Department of Reproductive & Sexual Health, Enfield Primary Care Trust, Enfield, UK.
R
R
Pittrof
S
S
Hitchings
M
M
FitzGerald
D002353:Carrier State / Q000175:diagnosis* / Q000453:epidemiology*; D003362:Cost-Benefit Analysis; D006069:Gonorrhea / Q000175:diagnosis* / Q000453:epidemiology*; D020010:Heterosexuality; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000191:economics* / Q000379:methods*; D009344:Neisseria gonorrhoeae / Q000302:isolation & purification; D021141:Nucleic Acid Amplification Techniques / Q000592:standards; D017410:Practice Guidelines as Topic; D012680:Sensitivity and Specificity; D006113:United Kingdom / Q000453:epidemiology